Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.968032
+0.042957 (4.64%)
At close: Aug 14, 2026
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $6.92 million as of August 14, 2026. Its market cap has decreased by -28.04% in one year.
Market Cap
6.92M
Enterprise Value
10.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.97
ChartMarket Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.35M to 6.92M, a decrease of -69.02%. That is a compound annual growth rate of -6.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 6.92M | 19.51% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 11.00M |
| Brainstorm Cell Therapeutics | 9.00M |
| Adaptimmune Therapeutics | 7.16M |
| Hepion Pharmaceuticals | 6.65M |
| Reviva Pharmaceuticals Holdings | 6.61M |
| America Great Health | 6.35M |
| TRON Group | 5.70M |
| LianMedical | 4.40M |